The blood beryllium lymphocyte proliferation test is used in medical surveillance to identify
both beryllium sensitization and chronic beryllium disease. Approximately 50% of …

We conducted a medical screening for beryllium disease of 577 former workers from a
beryllium processing facility. The screening included a medical and work history …

Rationale: Beryllium continues to have a wide range of industrial applications. Exposure to
beryllium can lead to sensitization (BeS) and chronic beryllium disease (CBD). Objectives …

We examined the relationship between exposure to beryllium and the presence of beryllium
sensitization (BeS) and chronic beryllium disease (CBD) in a cohort of workers in a beryllium …

Objective: People exposed to beryllium compounds are at increased risk of developing
beryllium sensitization and chronic beryllium disease (CBD). The purpose of this short …

We examined the epidemiology of chronic beryllium disease among a stratified, random
sample (n= 895) of nuclear weapons workers using the blood beryllium lymphocyte …

Background Chronic beryllium disease (CBD), which primarily affects the lungs, occurs in
sensitized beryllium‐exposed individuals. At a copper–beryllium alloy strip and wire …

The prevalence of beryllium sensitization and chronic beryllium disease by job category was
examined among individuals tested in the Rocky Flats Beryllium Health Surveillance …

Although beryllium disease has been associated with a bronchoalveolar lavage (BAL)
lymphocytosis and T cell-mediated immune response, we do not know if either the BAL …

Beryllium lung disease is a chronic granulomatous disorder in which a beryllium-specific
immune response plays a central role. By using a measure of cellular immune response to …